FLEXYLINK 4 - Linear Hyaluronic Acid with a High Viscosity Degree for Joints Affected by OA
One 4ml pre-filled syringe
TECHNOLOGICAL INNOVATION FOR OSTEOARTHRITIS THERAPY TREATMENT OF THE AFFECTED JOINTS
Innovative treatments based on high-viscosity linear hyaluronic acid for joints affected by OA
Flexylink 4
Linear Hyaluronic Acid 2% (HA obtained by Biofermentation)
EU Classification: Class III Medical Device
HA Molecular Chain : Linear
Origin: Biofermentation (Streptococcus Equi)
Volume (pre-filled syringe): 4ml
Molecular Weight: 1500 KDa
HA Concentration: 80mg/4ml (2%)
Dosage: 2 annual therapies with 2-3 injections, one every 15 days
Indications: Treatments for all joints
Packaging: Airless system (High Safety Profiles)